Israel Englander Bio N Tech Se Put Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$80.36 - $102.87 $225,008 - $288,036
-2,800 Reduced 11.24%
22,100 $1.78 Million
Q1 2024

May 15, 2024
SELL
$88.96 - $112.35 $3.22 Million - $4.07 Million
-36,200 Reduced 59.25%
24,900 $2.3 Million
Q4 2023

Feb 14, 2024
BUY
$90.91 - $112.75 $4.98 Million - $6.18 Million
54,800 Added 869.84%
61,100 $6.45 Million
Q2 2023

Aug 14, 2023
BUY
$102.58 - $129.66 $646,254 - $816,858
6,300 New
6,300 $679,000

Others Institutions Holding BNTX

# of Institutions
328
Shares Held
40.6M
Call Options Held
845K
Put Options Held
1.23M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email